- Price is above Fair Value, showing premium demand versus the model.
APEX
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Apex Frozen Foods Limited · Consumer Defensive · Farm Products
Latest close
376.8 INR
1.6%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -4.9% below the Trend Line and sits at 55.2% of its 52-week range. The latest completed week returned 1.6%, after a -3.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal.
Setup score
38
out of 100
Latest Close
376.8 INR
7 Aug 2026
1W Return
1.6%
latest completed week
4W Return
-3.5%
short-term follow-through
12W Return
-19.2%
quarterly tape
Trend Breadth
94.2%
49 of 52 weeks active
Volume Ratio
0.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 41.85% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.6%
Latest completed week; four-week move -3.5%.
Indicator stack
52/24
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.85%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
55/100
21 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -4.9% below the Trend Line and sits at 55.2% of its 52-week range. The latest completed week returned 1.6%, after a -3.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3712-week average 0.66
12-week confirmation
Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.37Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers
No recent accumulation markers. 3 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -3.5% over four weeks, -19.2% over 12 weeks, and 70.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year49
Trend breadth94.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.24Latest activity-pressure read.
Pressure change-39.2%Four-week change in activity pressure.
Leadership12.24Latest relative-leadership reading.
RS change-45.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 88%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength94/100Blend of value, momentum, and quality. Underlying universe rank 7; rank 1 is best.
Value72/100Relative valuation strength. Underlying universe rank 29; rank 1 is best.
Quality71/100Profitability and accounting quality. Underlying universe rank 30; rank 1 is best.
Momentum95/100Medium-term price momentum. Underlying universe rank 6; rank 1 is best.
Growth91/100Revenue and earnings growth. Underlying universe rank 10; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework24/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 30.3x Price divided by trailing earnings.
- Price / sales
- 1.3x Market value relative to trailing revenue.
- EV / EBITDA
- 16.0x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 7.7% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 33.3% Gross profit retained from each unit of revenue.
- Operating margin
- 4.3% Operating profit retained from revenue.
- Free-cash-flow margin
- 10.1% Free cash flow generated from revenue.
- Return on invested capital
- 5.5% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 14.8% Latest one-year revenue growth.
- EPS growth
- 902.1% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 98.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 9/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.5% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.5% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 21 relevant articles.
7 positive · 13 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-26.8%Distance below the 52-week high.
13-week volatility2.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+24.6%Week of 13 Feb.
Worst week-11.0%Week of 27 Feb.
Latest week+1.6%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains7
Flat weeks0
Modest losses8
Sharp losses6
Recent vol2.7%13-week weekly-return volatility.
Base vol8.6%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew7.9% / -5.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Consumer Defensive
4-week rank66 / 100
Group average-0.4%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD51.0%positive activity pressure
RS44.0%positive relative leadership
Four-week leaders
IndustryIN Farm Products
4-week rank14 / 21
Group average-1.0%
Trend breadth23.8%
Trend23.8%active weekly trend signals
MD38.1%positive activity pressure
RS33.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape42/100
Trend, activity pressure, participation, and risk combine to a 42/100 tape read.
Indicator analysis54/100Latest 12-week confirmation: trend 10/12, activity pressure 3/12, relative leadership 12/12.
Activity pressure 0.37; 3 reversal markers Next-Week ExpectancyNegative 41.85%Next-week expectancy is negative with a 41.85% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors82/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 23; Small Cap Core rank 36 SVQF24/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1194.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 21 relevant articles.
Tyson Foods (TSN) Q3 2026 Preview: EPS Est. $1.00, Reports August 3 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 376.8 INR | 1.6% | 396.3 INR | 265.2 INR | -1.24 | 12.24 | 291.9K | Off |
| 31 Jul 2026 | 370.6 INR | -2.7% | 392.4 INR | 264.1 INR | -1.22 | 12.26 | 268.0K | Off |
| 24 Jul 2026 | 381.0 INR | -4.8% | 389.9 INR | 263.2 INR | -1.15 | 19.35 | 433.7K | On |
| 17 Jul 2026 | 400.2 INR | 2.5% | 386.4 INR | 262.1 INR | -1.07 | 23.54 | 1.1M | On |
| 10 Jul 2026 | 390.5 INR | -3.3% | 382.6 INR | 260.9 INR | -0.89 | 22.33 | 494.3K | On |
| 3 Jul 2026 | 404.0 INR | -0.9% | 378.5 INR | 259.8 INR | -0.74 | 27.45 | 63.8K | On |
| 26 Jun 2026 | 407.8 INR | -2.8% | 373.9 INR | 258.5 INR | -0.65 | 31.17 | 0 | On |
| 19 Jun 2026 | 419.8 INR | 0.1% | 370.3 INR | 257.2 INR | -0.48 | 36.79 | 142.7K | On |
| 12 Jun 2026 | 419.1 INR | 2.1% | 367.3 INR | 255.9 INR | -0.30 | 40.62 | 456.5K | On |
| 5 Jun 2026 | 410.4 INR | -3.7% | 363.0 INR | 254.6 INR | 0.04 | 40.92 | 322.3K | On |
| 29 May 2026 | 426.3 INR | -5.0% | 357.1 INR | 253.2 INR | 0.55 | 47.24 | 1.7M | On |
| 22 May 2026 | 449.0 INR | -3.7% | 350.9 INR | 251.7 INR | 0.95 | 56.10 | 2.6M | On |
| 15 May 2026 | 466.0 INR | -5.4% | 344.0 INR | 250.1 INR | 1.22 | 65.20 | 3.3M | On |
| 8 May 2026 | 492.8 INR | 5.6% | 336.1 INR | 248.4 INR | 1.36 | 73.90 | 3.5M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.